Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance

Core Points - Iridex Corporation has received formal notice from Nasdaq confirming compliance with continued listing requirements [1] - The company had previously been notified of non-compliance due to insufficient stockholders' equity as reported in its quarterly filing [2] - Iridex regained compliance by meeting the minimum stockholders' equity requirement of $2,500,000 based on its quarterly report [3] Company Overview - Iridex Corporation is a leader in developing and marketing laser-based medical systems and devices for ophthalmology [4] - The company's proprietary MicroPulse technology offers effective treatment for eye conditions such as glaucoma and diabetic macular edema [4] - Iridex products are distributed in over 100 countries, with sales in the U.S. through a direct sales force and internationally via independent distributors [4]